SAVAGE BRIAN (Interim Chief Legal Officer) sold 9.4% of their position (1.13K shares) of TEVA PHARMACEUTICAL INDUSTRIES LTD on the open market
Open‑market sale worth $35.7K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/9/2026ACC: 0001193125-26-098501
Officer· Interim Chief Legal Officer
Since Mar 2026
-1.13K
Net shares
Net seller
$35.7K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
3.58K acquired · 4.71K disposed
Non-Derivative Transactions2
Ordinary Shares
Direct
Shares
+3.58K
Price / share
—
Trade value
—
% of position
42.3%
3/5/2026
8.46K→12.04K
Ordinary Shares
Direct
Shares
−1.13K
Price / share
$31.67
Trade value
$35.69K
% of position
9.4%
3/5/2026
12.04K→10.91K
Total
Net shares
+2.45K
Net value
-$35.69K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 3/5/2026 | M · Option Exercise | +3.58K | — | — | 42.3% | 8.46K | 12.04K |
| Ordinary Shares Direct | 3/5/2026 | S · Sale | −1.13K | $31.67 | $35.69K | 9.4% | 12.04K | 10.91K |
| Total | +2.45K | -$35.69K | ||||||
Derivative Transactions1
Restricted Share Units
Direct
Converts to
Ordinary Shares
3.58K shares
Shares
−3.58K
Strike price
Held after
10.74K
Exercisable
—
3/5/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Share Units Direct | Ordinary Shares3.58K shares | 3/5/2026 | M · Option Exercise | −3.58K | — | 10.74K |